Sheffield firms sign partnership deal

Two Sheffield companies, Arquella and Elaros, have signed a partnership deal to develop new products for care homes.

The deal matches Arquella’s understanding of the care home sector, with Elaros’ expertise in digital health products. Together, the two companies hope to expand their reach into the care home market.

Arquella have built a successful business delivering nurse call systems and falls prevention equipment to care homes. Elaros, a digital health company, has developed several healthcare products, including a hydration monitoring system for care homes.

Reuben Timoney, Director of Arquella, said: “This partnership will help both companies achieve their goals of building excellent products for the care home market, by expanding the range of products each are currently able to offer.”

He added, “Arquella will be launching a new product platform that will be able to incorporate Elaros’ existing digital care home products, expanding our portfolio”

Care homes cater for a population of over 400,000 people in the UK, a number which is set to increase as the population ages. The rising demand, combined with the reduction in funding for adult social care will increase the challenges faced by care homes. The adoption of technology, is seen as a way of helping them provide high quality care to their residents and a means of reducing the time spend by care home workers completing paperwork.

Professor Paul O’Brien CEO of Elaros said, “Elaros’ ethos is to develop products that address unmet needs. We have been working in the digital health arena for seven years and from previous project work, are aware that the uptake of digital products to help care home staff in their working day, lags behind its potential.”

One issue faced by care homes is the ability to keep track of how much residents drink each day, to ensure that they don’t become dehydrated. The first Elaros product to be launched through Arquella’s platform will be the hydration monitoring app, Hydr8.

He added, “Through this partnership both companies hope to advance the uptake of technology in care homes. Arquella gain access to the products that we are developing and Elaros gains access to an established customer base”.

Both Arquella and Elaros have a desire to help care homes deliver the best possible care to their residents and believe that their collaboration will help put this into practice.

Arquella (left) and Elaros (right) conclude their partnership meeting, 24th April, 2019.

ENDS

Notes to Editors:

Press contacts

Professor Paul O’Brien

E-mail: paul.obrien@elaros.com

Tel: 07970933272

Web: www.elaros.com

Paul Howell

Email: paulhowell@arquella.co.uk

Tel: 07971560292

Web: www.arquella.co.uk

About Arquella Ltd

Arquella capitalises on many years’ experience providing systems for care homes. In particular, nurse call systems. Arquella are building on this deep experience by delivering ongoing maintenance requirements, new installations and providing a wide range of other accessories, including falls prevention and monitoring equipment.

Arquella’s objective is to provide solutions in the pursuit of excellence of operations for the care home market. This will include both data solutions and physical products, the first of which is a new nurse call system to be released Summer 2019.

 About Elaros Ltd:

Elaros is a Sheffield based digital health company that counts four NHS organisations amongst its shareholders (a Teaching Hospital, two NHS Regional Innovation Hubs – of which Medipex Ltd, and a Clinical Commissioning Group).

Over the past four years the Company has been working to build out a broad portfolio of digital health products around the needs of children, and a suite of products for older people.

In addition to developing our own digital solutions we have been commissioned to create other organisations non-competing digital solutions under contract, including a Clinical Commissioning Group.

As a digital company, created by clinicians, all of our product development is based firmly on; addressing unmet clinical needs, backed up by clinical evidence, co-created (with patients, users and clinicians) and then clinically validated/tested (pilots, trials and CE marking).

Subscribe

Sign up to our e-newsletter for all the latest news and updates from Medipex.

*All fields are required